Sign In
Buy BMRN
$56.47
+1.81 (+3.31%)
At Close: Jun 04, 2026
BioMarin to Host Second Quarter 2020 Financial Results Conference Call and Webcast on Tuesday, August 4 at 4:30pm ET
08:30am, Tuesday, 21'st Jul 2020
SAN RAFAEL, Calif., July 21, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc.
ClearBridge Sustainability Leaders Strategy Portfolio Manager Commentary Q2 2020
10:00am, Monday, 20'th Jul 2020
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas
Telemus Capital LLC Buys New Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
08:20am, Sunday, 19'th Jul 2020
Telemus Capital LLC bought a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commissio
Harbor Investment Advisory LLC Grows Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
05:42am, Saturday, 18'th Jul 2020
Harbor Investment Advisory LLC grew its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) by 561.8% in the 2nd quarter, according to the company in its most recent 13F filing with the S
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Position Trimmed by IFM Investors Pty Ltd
08:35pm, Thursday, 16'th Jul 2020
IFM Investors Pty Ltd decreased its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) by 29.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securi
Insider Selling: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Insider Sells 23,011 Shares of Stock
04:30am, Thursday, 16'th Jul 2020
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) insider Henry J. Fuchs sold 23,011 shares of BioMarin Pharmaceutical stock in a transaction dated Monday, July 13th. The shares were sold at an average price
BioMarin Pharmaceutical: Create A Covered Call Dividend (NASDAQ:BMRN)
02:39pm, Tuesday, 14'th Jul 2020
BMRN is an ideal candidate for a covered call strategy. Set the investment framework (financial and mental parameters), check out the options ladder and execute the trade.
BioMarin Pharmaceutical: Create A Covered Call Dividend
10:39am, Tuesday, 14'th Jul 2020
BMRN is an ideal candidate for a covered call strategy. Set the investment framework (financial and mental parameters), check out the options ladder and execute the trade.
It's Been A Rough 6 Months For Stock-Picking Gurus
06:22am, Tuesday, 14'th Jul 2020
Some of the best stock-pickers working today are having a rough go of it. It's not surprising that many of them are struggling, just as the rest of us mere mortals are.
Pfizer Surges On Fast Track For Coronavirus Vaccine — But Is PFE Stock A Buy?
02:30pm, Monday, 13'th Jul 2020
Pfizer stock is forming a cup-with-handle base as the Street intently watches its coronavirus vaccine efforts with BioNTech. But is the pharmaceutical company's stock a buy right now?
Pfizer Surges On First Coronavirus Vaccine Test — But Is PFE Stock A Buy?
12:00pm, Monday, 13'th Jul 2020
Pfizer stock is forming a cup-with-handle base as the Street intently watches its coronavirus vaccine efforts with BioNTech. But is the pharmaceutical company's stock a buy right now?
Top Stocks To Buy On A Sell-Off
11:29am, Monday, 13'th Jul 2020
Let your winners continue winning, but begin compiling a watch list to buy on a pullback. These top-ranked industries are the best hunting ground for ideas.
ClearBridge Mid Cap Strategy Portfolio Manager Commentary Q2 2020
12:40pm, Saturday, 11'th Jul 2020
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas
Wonder drug to treat PKU could soon be available on NHS after 11-year battle
11:53am, Saturday, 11'th Jul 2020
A DRUG that will change the lives of patients with a rare genetic disorder could soon be available on the NHS after an 11-year battle.
